Navigation and service


Cookies help us to provide our services. By using our website you agree that we can use cookies. Read more about our Privacy Policy and visit the following link: Privacy Policy


Guidance for occupational physicians and health and safety professionals in the treatment of beryllium exposure

Project number: F 2061 Institution: Federal Institute for Occupational Safety and Health (BAuA) Status: Completed Project


Chronic beryllium disease (CBD) is a granulomatous disorder and a perfect pheno-copy of sarcoidosis. Therefore misdiagnoses are easily possible. Germany has no uniform recommendations as to how occupational CBD should be diagnosed. A guideline for a standardised diagnostic procedure and a checklist with questions on typical occupational beryllium exposures are going to be developed for physicians.



Unit 3.3 "Evidence-based Occupational Health, Workplace Health Management"

Phone: +49 231 9071-1971 Fax: +49 231 9071-2070